WebRAYMOND F SCHINAZI AND FAMILY FOUNDATION INC. Defined as: Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for … WebRaymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing …
Enhanced Antiviral Benefit of Combination Therapy with …
Raymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing treatments for infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), herpes, dengue fever, zika, … See more Schinazi was born on March 21, 1950, in Alexandria, Egypt to Jewish parents. In 1962, his family was sequestered by the Nasser regime and in 1964 they immigrated to Naples, Italy as refugees. Schinazi went to … See more Schinazi's work led to the discovery of a second nucleoside analog, emtricitabine (FTC), subsequently resulting in a potent, safe nucleoside … See more In 2004, Schinazi was one of the founders of Pharmasset, a company that would later go on to develop sofosbuvir. The name Pharmasset was … See more In 2024, Schinazi received the Chevalier de la Légion d’honneur, the French Legion of Honor, with the rank of knight. Established in 1802 by Napoleon Bonaparte, it is the highest decoration bestowed in France and recognizes outstanding service to the French Republic. He … See more Schinazi is currently the Frances Winship Walters Professor of Pediatrics, Director of the Laboratory of Biochemical Pharmacology, and co-Director of the HIV Cure Scientific … See more Among the first drugs discovered and developed for treatment of HIV came through the collaboration between Dr. Dennis Liotta (Emory) and Schinazi. In 1992, they first published on lamivudine (3TC) in Antimicrobial Agents and Chemotherapy. This … See more Schinazi has also had a hand in the development of the other FDA-approved drugs Stavudine, Lamivudine, and Telbivudine. See more WebRaymond F Schinazi, Frances Winship Walters Professor of Pediatrics, Center for AIDS Research, Emory University School of Medicine, Atlanta, Georgia 30033, USA., ... Weilert F, et al. Phase 1b efficacy and safety of NVR 3-778, a first-in-class HBV core inhibitor, in HBeAg-positive patients with chronic HBV infection. Hepatology. 2015; 62:1385A. fluid filled blisters on toes
@drugbuster21 Twitter
WebRaymond F. Schinazi * Center for ViroScience/Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, and Children’s Healthcare of Atlanta, 1760 Haygood Drive, Atlanta, GA 30322, USA * Authors to whom correspondence should be addressed. Web雷蒙德·夏納茲（Raymond Schinazi）博士，博士 埃默里大學艾滋病研究中心. 2013 查爾斯·賴斯博士 洛克菲勒大學. 2012 醫學博士艾倫·沃爾科夫（Allan W.Wolkoff） 阿爾伯特·愛因斯坦醫學院. 2011 醫學博士Robert H.Purcell 國家衛生研究院. 2010 醫學博士George K.Michalopoulos ... WebJul 4, 2024 · Dr. Raymond F. Schinazi is the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University. He … fluid filled blisters rash